Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
Western blot (applications tested for the base form of this product only)
Human EGLN2 / PHD1
Human, Mouse (tested or 100% immunogen sequence identity)
Western blot (1:500 - 1:2500)
(applications tested for the base form of this product only)
Specificity and Use
EGLN2 / PHD1 antibody was raised against the epitope maps to a region between residue 350 and the C-terminus (residue 407) of human Prolyl Hydroxylase Domain-Containing Protein 1 using the numbering given in entry NP_444274.1 (GeneID 112398)
Cellular oxygen sensor that catalyzes, under normoxic conditions, the post-translational formation of 4-hydroxyproline in hypoxia-inducible factor (HIF) alpha proteins. Hydroxylates a specific proline found in each of the oxygen-dependent degradation (ODD) domains (N-terminal, NODD, and C-terminal, CODD) of HIF1A. Also hydroxylates HIF2A. Has a preference for the CODD site for both HIF1A and HIF2A.